Christobel Selecky serves as Executive at ImmunityBio, Inc., where they oversee executive responsibilities. Since joining the company, Christobel Selecky has executed 9 insider transactions totaling $687.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 23, 2026 involved exercising options for 25,000 shares valued at $0.
Christobel Selecky currently holds 67,937 shares of ImmunityBio, Inc. (IBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christobel Selecky has been a net seller of IBRX stock. They have purchased $0 and sold $687.6K worth of shares.
Christobel Selecky's most recent insider trade was on Feb 23, 2026, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $10.00 |
| Discretionary |
| Feb 23, 2026 | IBRX | $74.5K | Option Exercise | 25,000 | $2.98 | Discretionary |
| Jan 20, 2026 | IBRX | $0 | Option Exercise | 25,000 | $N/A | Discretionary |
| Jan 20, 2026 | IBRX | $187.7K | Sale | 25,000 | $7.51 | Discretionary |
| Jan 20, 2026 | IBRX | $74.5K | Option Exercise | 25,000 | $2.98 | Discretionary |
| Jan 16, 2026 | IBRX | $0 | Option Exercise | 50,000 | $N/A | Discretionary |
| Jan 16, 2026 | IBRX | $250.0K | Sale | 50,000 | $5.00 | Discretionary |
| Jan 16, 2026 | IBRX | $149.0K | Option Exercise | 50,000 | $2.98 | Discretionary |